Mira Pharmaceuticals Inc (MIRA)
1.1600 x 3 1.2200 x 3
Pre-market by (Cboe BZX)
1.2200 -0.0100 (-0.81%) 03/25/25 [NASDAQ]
1.1600 x 3 1.2200 x 3
Pre-market 1.2200 unch (unch) 16:00 ET
for Tue, Mar 25th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | |
Operating Expenses | 8,526 | 7,048 |
Operating Income | -8,526 | -7,048 |
Interest Expense | 3,456 | 10 |
Pre-tax Income | -11,982 | -7,058 |
Net Income Continuous | -11,982 | -7,058 |
Net Income | $-11,982 | $-7,058 |
EPS Basic Total Ops | -0.64 | -0.40 |
EPS Basic Continuous Ops | -0.65 | -0.40 |
EPS Diluted Total Ops | -0.64 | -0.40 |
EPS Diluted Continuous Ops | -0.65 | -0.40 |
EPS Diluted Before Non-Recurring Items | -0.64 | N/A |
EBITDA(a) | $-7,794 | $-7,048 |